#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4818	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2357	604.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1765	1765	T	711	T,G	626,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4818	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2357	604.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1499	1499	C	706	C,T	609,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4818	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2357	604.7	0	HET	.	.	.	A922G	.	922	922	A	1237	1237	A	723	A,G	478,154	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7350	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3908	563.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1873	1873	A	599	A	527	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7350	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3908	563.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2507	2507	C	700	C,T	602,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7350	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3908	563.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2581	2581	A	721	A,C	615,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7350	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3908	563.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3133	3133	C	599	C	525	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	27	790	folP	852	852	99.88	folP.l6.c30.ctg.1	1807	131.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	283	1678	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3970	126.8	1	SNP	p	S91F	0	.	.	271	273	TCC	735	737	TCC	155;157;158	T;C;C	132;139;134	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	283	1678	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3970	126.8	1	SNP	p	D95G	0	.	.	283	285	GAC	747	749	GAC	159;160;160	G;A;C	140;139;141	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	283	1678	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3970	126.8	1	SNP	p	D95N	0	.	.	283	285	GAC	747	749	GAC	159;160;160	G;A;C	140;139;141	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	654	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1562	124.8	0	.	p	.	0	A39T	NONSYN	115	117	GCC	582	584	ACC	175;176;176	A,C;C;C	144,1;150;148	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	654	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1562	124.8	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	780	782	CAC	189;189;189	C;A;C	157;159;161	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	654	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1562	124.8	0	.	p	.	0	E117K	NONSYN	349	351	GAA	816	818	AAA	188;187;186	A;A;A	158;156;154	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	654	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1562	124.8	1	SNP	p	G45D	0	.	.	133	135	GGC	600	602	GGC	178;179;179	G;G;C	149;153;155	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	422	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c17.ctg.1	1287	98.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1530	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3334	137.8	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1829	1831	GCA	201;201;202	G;C;A	169;174;170	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1530	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3334	137.8	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2312	2314	ATT	153;152;153	A;T;T	141;138;138	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1530	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3334	137.8	1	SNP	p	D86N	0	.	.	256	258	GAC	782	784	GAC	182;182;182	G;A;C	157;153;153	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1530	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3334	137.8	1	SNP	p	S87R	0	.	.	259	261	AGT	785	787	AGT	181;181;182	A,C;G;T	154,1;156;154	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1530	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3334	137.8	1	SNP	p	S87W	0	.	.	259	261	AGT	785	787	AGT	181;181;182	A,C;G;T	154,1;156;154	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1530	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3334	137.8	1	SNP	p	S87I	0	.	.	259	261	AGT	785	787	AGT	181;181;182	A,C;G;T	154,1;156;154	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1530	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3334	137.8	1	SNP	p	S88P	0	.	.	262	264	TCC	788	790	TCC	182;183;182	T,G;C;C	155,1;158;156	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1508	parE	1986	1986	99.9	parE.l6.c4.ctg.1	2871	157.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1671	1673	GGC	188;188;189	G;G;C	167;168;169	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.002	penA.22.002	1	1	27	1334	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2743	145.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1404	1406	GCA	189;190;190	G;C;A	164;162;162	penA.22.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1334	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2743	145.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1407	1409	ATC	190;190;190	A;T;C	163;159;162	penA.22.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1334	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2743	145.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1419	1421	GTG	192;189;190	G;T;G	160;161;162	penA.22.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1334	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2743	145.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1419	1421	GTG	192;189;190	G;T;G	160;161;162	penA.22.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1334	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2743	145.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1923	1925	ACC	153;154;152	A;C;C	140;141;142	penA.22.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1334	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2743	145.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1977	1979	GCG	150;150;151	G;C,G;G	130;115,1;127	penA.22.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1334	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2743	145.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1977	1979	GCG	150;150;151	G;C,G;G	130;115,1;127	penA.22.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1334	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2743	145.6	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2100	2102	GGT	159;160;160	G,C;G;T	130,2;138;130	penA.22.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1334	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2743	145.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2109	2111	GGC	159;159;158	G,C;G;C	134,1;137;131	penA.22.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1334	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2743	145.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2127	2129	CCG	161;161;163	C;C,A;G	130;135,1;135	penA.22.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1668	ponA	2397	2397	99.96	ponA.l15.c17.ctg.1	3439	145.2	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1787	1789	CTG	162;163;163	C;T;G	136;136;140	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	860	porA	1146	1146	99.65	porA.l15.c17.ctg.1	2124	121.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	723	723	C	137	C	115	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	948	porB1b	1047	1047	98.95	porB1b.l6.c30.ctg.1	1715	158.1	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	889	891	CAA	200;199;200	C;A;A	169;170;171	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	948	porB1b	1047	1047	98.95	porB1b.l6.c30.ctg.1	1715	158.1	0	.	p	.	0	G203S	NONSYN	607	609	GGC	1069	1071	AGC	203;202;201	A;G;C,G	179;176;175,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	948	porB1b	1047	1047	98.95	porB1b.l6.c30.ctg.1	1715	158.1	0	.	p	.	0	E212G	NONSYN	634	636	GAA	1096	1098	GGT	202;201;201	G;G;T	178;177;176	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	948	porB1b	1047	1047	98.95	porB1b.l6.c30.ctg.1	1715	158.1	0	.	p	.	0	H213D	NONSYN	637	639	CAT	1099	1101	GAT	203;203;201	G;A;T	176;177;174	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	948	porB1b	1047	1047	98.95	porB1b.l6.c30.ctg.1	1715	158.1	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1105	1107	GCT	203;204;203	G;C;T	177;180;179	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	948	porB1b	1047	1047	98.95	porB1b.l6.c30.ctg.1	1715	158.1	0	.	p	.	0	I218M	NONSYN	652	654	ATC	1114	1116	ATG	194;195;196	A;T;G	173;172;171	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	948	porB1b	1047	1047	98.95	porB1b.l6.c30.ctg.1	1715	158.1	0	.	p	.	0	R257K	NONSYN	769	771	AGG	1231	1233	AAG	183;183;184	A;A,G;G	158;156,1;155	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	948	porB1b	1047	1047	98.95	porB1b.l6.c30.ctg.1	1715	158.1	1	SNP	p	G120K	0	.	.	358	360	GGC	820	822	GGC	223;220;217	G;G;C	189;184;187	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	3026	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5194	174.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2192	2194	CAT	186;185;185	C;A;T	161;158;159	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	512	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1298	118.2	1	SNP	p	V57M	0	.	.	169	171	GTG	699	701	GTG	205;204;206	G;T;G	182;181;183	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
